Skip to main content
KTTA
NASDAQ Life Sciences

Pasithea Therapeutics' 2025 10-K Reveals $20.4M Net Loss, Widening from Previous Year

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.715
Mkt Cap
$16.51M
52W Low
$0.281
52W High
$3.79
52W Position info
154% above low
Off High info
81% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

KTTA has more than doubled off its 52-week low of $0.281 on light trading volume (0.2× avg).

Summary

Pasithea Therapeutics reported a significant net loss of $20.428 million and an operating loss of $20.857 million for the year ended December 31, 2025, as disclosed in its 10-K filing. This net loss represents a substantial increase from the $13.905 million loss reported in 2024, primarily driven by higher general and administrative and research & development expenses. For a micro-cap company, these material losses highlight a considerable cash burn rate. While the company noted it raised significant equity in 2025 to provide a multi-year runway and is advancing its PAS-004 clinical program, the widening losses will be a key concern for investors. Traders will closely watch the company's cash position and future financing activities as it continues its clinical development.

At the time of this announcement, KTTA was trading at $0.72 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $16.5M. The 52-week trading range was $0.28 to $3.79. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

KTTA - Latest Insights

KTTA
Nov 17, 2026, 8:42 PM EST
Filing Type: 4
Importance Score:
8
Price at Filing: $0.4343
Real-time Price: $0.4819 info
Change: +$0.0476 (+11%) info
Market Cap: $17.678M info
KTTA
Nov 13, 2026, 5:17 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $0.479
Real-time Price: $0.4819 info
Change: +$0.0029 (+0.61%) info
Market Cap: $17.678M info
KTTA
Nov 13, 2026, 2:00 AM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.510
Real-time Price: $0.4819 info
Change: -$0.0281 (-6%) info
Market Cap: $17.678M info
KTTA
Nov 03, 2026, 7:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.3591
Real-time Price: $0.4819 info
Change: +$0.1228 (+34%) info
Market Cap: $17.678M info
KTTA
Sep 14, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.550
Real-time Price: $0.4819 info
Change: -$0.0681 (-12%) info
Market Cap: $17.678M info